The Food and Drug Administration has issued a Class I recall correction for certain Boston Scientific ACCOLADE pacemakers and cardiac resynchronization therapy pacemakers after identifying a software- ...
Microsoft Threat Intelligence is warning of a large scale, multistage phishing campaign that disproportionately targeted the health care sector, sending “code of conduct” themed emails to lure users ...
USA Today published a column by AHA Board Chair Marc Boom, M.D., president and CEO of Houston Methodist, highlighting how ...
The measles outbreak in Utah that began in June 2025 has grown to 638 cases as of May 5, according to the state’s Department ...
Behind every hospital door is an extraordinary group of people who have chosen a calling rooted in compassion, skill and ...
The AHA shared the following statement with the media in response to a report released May 7 by Families USA. “This report is ...
The Department of Health and Human Services published an interim final rule May 7 to delay compliance dates for entities ...
A May 4 guest essay published in The New York Times frames hospitals as the leading “culprit” behind rising health care costs. It reduces a complex health care system and a much-need conversation on ...
The Centers for Medicare & Medicaid Services announced May 6 that it will provide access to certain glucagon-like peptide-1 ...
The Food and Drug Administration announced May 6 that it is aware of a shortage of neurosurgical patties, sponges and strip devices across the U.S. due to supplier issues, and expects the issue to ...
The Honorable Roger Marshall, M.D. United States Senate 479A Russell Senate Office Building Washington, DC 20510 The Honorable Sheldon Whitehouse United States Senate 530 Hart Senate Office Building ...
The AHA May 7 wrote to House and Senate lawmakers in support of the Medicare Advantage Improvement Act (H.R. 8375/S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results